Biology subjects

Camma, C.

Publications and source records attributed to Camma, C..

3 recordsLinked to original sources

bioRxiv2025

Clinical and molecular characterisation of primary refractoriness to atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma.

BackgroundDespite improved outcomes with atezolizumab plus bevacizumab (A+B) in hepatocellular carcinoma (HCC), primary refractoriness (PRef), characterised by early progression or short-lived disease stabilisation following treatment, remains a significant and poorly understood clinical challenge. MethodsWe analysed 1296 patients with HCC and Child-Pugh A liver cirrhosis treated with frontline A+B (AB-real) and validated findings in 645 trial participants recruited to IMbrave150 and GO30140. PRef was defined by Society for the Immunotherapy of Cancer (SITC) criteria as progressive disease in the first 6 months after treatment initiation. Patients who achieved complete response, partial response or stable disease for [≥] 6 months were classified as responders. We performed a multi-parametric analysis of pre-treatment tumour tissue including machine learning-based quantification of tumour-infiltrating lymphocytes, imaging mass cytometry and RNA sequencing (RNAseq) to evaluate differences in the tumour microenvironment (TME) of PRef versus responding patients. We employed conditional inference tree analyses to provide a hierarchical organisation of determinants of PRef. ResultsAmong 677 AB-real and 378 trial patients evaluable by SITC criteria, PRef identified inferior median OS in comparison with responding patients (AB-real: 7.3 vs. 31.5 months, HR 3.7, 95%CI 2.8-8.5, p<0.001; Trials: 10.8 vs. NR, HR 4.6, 95%CI 3.3-6.3, p<0.001). PRef patients exhibited higher baseline systemic inflammation (neutrophil-to-lymphocyte ratio, NLR [≥]3), a distinctively immunosuppressive TME enriched in CD163+ tumour-associated macrophages and a higher Treg/Teff ratio. RNAseq of tumour tissue demonstrated lower intrinsic immunogenicity in PRef samples, characterised by repressed IFN-{gamma} and Teff signatures, with elevated myeloid infiltration. Conditional inference tree analysis identified IFN-{gamma} signature downregulation combined with NLR [≥]3 as the strongest contributor of PRef. ConclusionsPRef to A+B identifies a distinct biological entity characterised by unopposed systemic inflammation, myeloid cell infiltration and T-cell depletion. Targeting myeloid-mediated immunosuppression, particularly in patients with low IFN-{gamma} signature expression and elevated NLR might enhance responsiveness to A+B. HighlightsO_LIPrimary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma, as defined by SITC criteria, is associated with poor clinical outcomes. C_LIO_LITumour microenvironment profiling reveals an immunosuppressive phenotype characterized by high myeloid infiltration, reduced interferon-{gamma} signalling, and T-cell depletion. C_LIO_LIThe combination of systemic inflammation and low IFN-{gamma} signature expression strongly predicts primary refractoriness and may inform therapeutic decision-making. C_LI

cancer biology↗

bioRxiv2024

Insect-specific Alphamesonivirus-1 (Mesoniviridae) in lymph node and lung tissues from two horses with acute respiratory syndrome

As members of the RNA virus order Nidovirales include those that infect hosts ranging from marine invertebrates to terrestrial mammals, understanding their emergence, host range and disease potential is of clear importance. The Mesoniviridae are a recently documented family of viruses within the Nidovirales. To date, mesoniviruses have only been associated with the infection of arthropods, particularly mosquitoes. Herein, we report the first detection of a mesonivirus - Alphamesonivirus-1 - in mammals. Specifically, we utilized genomic and histological techniques to identify the presence of Alphamesonivirus-1 in lung and lymph node tissues of two horses that succumbed to an acute respiratory syndrome. Notably, no other pathogens typically associated with respiratory disease in horses were detected in these samples. Counter to the previous contention that mesoniviruses only infect insects, our findings suggest a potentially broader host range and cross-species transmission of these viruses. The genome sequences of Alphamesonivirus-1 obtained from the two horses were closely related to those from a local Culex mosquito pool as well as an Alphamesonivirus-1 previously in identified Italy, suggestive of ongoing local transmission. The discovery of Alphamesonivirus-1 in tissues from diseased horses not only challenges current understandings of mesonivirus host range, but prompts further investigation into the role of insect-specific viruses in mammalian disease processes. Our results emphasize the importance of considering atypical pathogens in cases of unexplained animal deaths and suggest a potential zoonotic threat posed by previously overlooked viral families. IMPORTANCEAlphamesoniviruses, members of the Mesoniviridae family, have long been considered insect-specific viruses with no known association with vertebrate hosts. Herein, we describe the first detection of Alphamesonivirus-1 in mammals, marking a significant expansion of the known host range for this newly described virus family. Using detailed molecular and histological analyses we identified Alphamesonivirus-1 in lung and lymph node tissues of two horses that presented with an acute respiratory syndrome. Our findings indicate that Alphamesoniviruses may possess a broader host range than previously believed and could potentially induce severe disease in mammals. This unexpected host jump not only challenges existing knowledge on the ecology of mesoniviruses, but suggests that insect-specific viruses may pose a previously unrecognized health risk to vertebrates, including domesticated animals. These insights prompt the need for increased surveillance of atypical pathogens, especially in cases of unexplained respiratory illness, and may have implications for zoonotic disease emergence.

microbiology↗

bioRxiv2018

Core Genome Multi Locus Sequence Typing and Single Nucleotide Polymorphism Analysis in the Epidemiology of Brucella melitensis Infections

The use of whole genome sequencing (WGS) using next generation sequencing (NGS) technology has become a widely accepted method for microbiology laboratories in the application of molecular typing for outbreak tracing and genomic epidemiology. Several studies demonstrated the usefulness of WGS data analysis through Single Nucleotide Polymorphism (SNP) calling from a reference sequence analysis for Brucella melitensis, whereas gene-by-gene comparison through core-genome Multilocus Sequence Typing (cgMLST) has not been explored so far. The current study developed an allele-based method cgMLST and compared its performance to the genome-wide SNP approach and the traditional MLVA on a defined sample collection. The dataset comprised of 37 epidemiologically linked animal cases of brucellosis as well as 71 epidemiologically unrelated human and animal isolates collected in Italy. The cgMLST scheme generated in this study contained 2,687 targets of the B. melitensis 16M reference genome (75.4% of the complete genome). We established the potential criteria necessary for inclusion of an isolate into a brucellosis outbreak cluster to be [≤]4 loci in the cgMLST and [≤]10 in WGS SNP analysis. CgMLST and SNP analysis provided much higher phylogenetic distance resolution than MLVA, particularly for strains belonging to the same lineage thus allowing diverse and unrelated genotypes to be identified with greater confidence. The application of this cgMLST scheme to the characterization of B. melitensis strains provided insights into the epidemiology of this pathogen and it is a candidate to be a benchmark tool for outbreak investigations in human and animal brucellosis.

microbiology↗